Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-04-03 @ 10:29 AM
Study NCT ID:
NCT01949532
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2013-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CFZ001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None